ALNY stock pitch - 2023-10-13

Added to YB: 2023-10-13

Pitch date: 2023-10-13

Alnylam Pharmaceuticals, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Market Cap

$59.3B

Pitch Price

$167.94

Price Target

N/A

Dividend

N/A

EV/EBITDA

153.82

P/E

1.4K

EV/Sales

18.50

Sector

Biotechnology

A summary for this pitch has not been created yet.